Otl38 ovarian cancer
WebJun 15, 2016 · In 12 patients with ovarian cancer, OTL38 accumulated in folate receptor alpha-positive tumors and metastases, enabling the surgeon to resect an additional 29% … WebOct 15, 2024 · "The data from this study show that OTL38 can intraoperatively identify more ovarian cancer lesions during cytoreductive surgery than traditional detection techniques alone which enables a better outcome for patients," said Chris Barys, CEO of On Target Laboratories. "OTL38 is the first of a portfolio of imaging agents designed to give …
Otl38 ovarian cancer
Did you know?
WebA Pilot Single dose Open-Label Study of OTL38 Injection (OTL38) for Intra-Operative Imaging of Folate Receptor Positive Ovarian Cancer Comparing ... This is a small scale investigational study to compare different fluorescent camera imaging systems against the current standard (Visionsense VS3 ... WebSep 7, 2024 · A Phase III Study of Pafolacianine Injection (OTL38) for Intraoperative Imaging of Folate Receptor–Positive Ovarian Cancer (Study 006) Journal of Clinical …
WebJul 31, 2024 · Janos Tanyi, MD, PhD, from the Perelman School of Medicine at the University of Pennsylvania, is conducting studies with OTL38, a contrast agent unrelated to ICG, in women with ovarian cancer. OTL38 … WebApr 5, 2024 · OTL38 is a ligand that targets folate receptors that appear in various types of cancers. Linked with a near-infrared dye, it allows surgeons to visually identify cancer cells that can guide them in removing the cancer tissue.
WebDec 7, 2024 · Pafolacianine injection (OTL38) with real-time, near-infrared fluorescence imaging may offer an adjunct to current surgical methods to detect additional ovarian cancer lesions that might otherwise ... WebJan 27, 2024 · OTL38 is believed to be the first targeted fluorescent marker to provide this type of benefit for lung cancer. The OTL38 technology is different in its ability to detect cancerous tissue not...
WebBackground: Pafolacianine sodium is under investigation as an adjunct to visual inspection and palpation by providing intra-operative imaging of folate receptor positive (FR+) ovarian cancer. Since complete resection (R0) is the strongest predictor of overall survival, methods to enhance detection of lesions are expected to benefit patient outcomes.
WebJul 27, 2024 · OTL38 is a folate-indole-cyanine green-like conjugate to folate receptor alpha (FRa). and positive predictive value (PPV)) of OTL38 for intraoperative imaging during epithelial ovarian cancer surgery. iowa state university livestock judging campWebJun 9, 2024 · Phase III trial of pafolacianine sodium injection plus fluorescent imaging for resection of ovarian cancer from ASCO 2024 as reported by Clinical Care Options … iowa state university loanWebMay 28, 2024 · Gynecologic Cancer Phase 3, randomized, single-dose, open-label study to investigate the safety and efficacy of pafolacianine sodium injection (OTL38) for … iowa state university licensinghttp://www2.doctorpda.cn/news/746761 open house invitations freeWebJun 8, 2024 · The Phase 3 study is to confirm the efficacy of OTL38 in combination with fluorescent light to detect additional Folate Receptor-positive (FR+) ovarian cancer … iowa state university livestock judging teamWebSep 15, 2024 · Ovarian Cancer Emerging Drugs Tisotumab Vedotin: Genmab Tisotumab vedotin, also known as HuMax-TF, HuMax®-TF-ADC, or TF-011-MMAE, is an antibody-drug conjugate (ADC) targeted to tissue factor... open house japan companyWebMay 20, 2024 · Pafolacianine. Pafolacianine is an optical imaging agent indicated in adult patients with ovarian cancer as an adjunct for intraoperative identification of malignant … open house invitation sample